Parkinson’s Disease Drugs Industry Global Report Analysis, Therapy levodopa therapy, dopamine therapy, MAO-B inhibitor therapy, COMT inhibitor therapy

Press Release: Pune, India- August , 2017

Global Parkinson’s Disease Drugs Market Outlook 2022

Description:

Parkinson’s disease belongs to the group of conditions called motor system disorders. This disease is a result of loss of dopamine producing neurons in the brain. The four primary symptoms of Parkinson’s disease are tremors, rigidity, slowness of movement and postural instability. Although, there is no cure for Parkinson’s disease, several medications are used to suppress the symptoms of the disease.

Scope of the Report: 
As per RNCOS report “Global Parkinson’s Disease Drugs Market Outlook 2022”, the global Parkinson’s disease drugs market is anticipated to witness a moderate growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global Parkinson’s disease drugs market. The report provides insight about the major drivers, such as increasing awareness about Parkinson’s disease and its treatment options, research grants and funds, for the global Parkinson’s disease drugs market.

Furthermore, few challenges, such as patent expiry and high cost of treatment, which are hindering the growth of the global Parkinson’s disease drugs market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Parkinson’s disease drugs market. 

 For Sample Report@ https://www.wiseguyreports.com/sample-request/1748998-global-parkinson-s-disease-drugs-market-outlook-2022

The global Parkinson’s disease drugs market has been segmented on the basis of type of therapy into levodopa therapy, dopamine therapy, MAO-B inhibitor therapy, COMT inhibitor therapy, and other types of therapies. Among all the types, levodopa therapy is the first and most potent treatment for the Parkinson’s disease. The benefits of the medication are witnessed soon after administration.

Apart from these types of therapies, various pharmaceutical and biotech companies are also developing stem cell therapy for the treatment of Parkinson’s disease. Stem cell therapy is an evolving field which makes use of stem cells to treat or prevent a disease or condition, such as Parkinson’s disease. Even a minimal success from this procedure can mean significant improvement in quality of life for patients.

Numerous companies, such as SanBio Inc and International Stem Cell Corp, are carrying out clinical trials for stem cell therapies for the treatment of Parkinson’s disease. Hence, stem cell therapy presents great opportunities for the growth of global Parkinson’s disease drugs market in the coming years.

Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America accounted for the largest share in the global Parkinson’s disease drugs market. Moreover, the report also highlights various mergers and acquisitions taking place in the global Parkinson’s disease drugs industry. The drugs pipeline of Parkinson’s disease has also been mentioned in the report.

The last section of the report discusses about the prominent players in global Parkinson’s disease drugs market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios and product pipeline. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Parkinson’s disease drugs market.

 For any Enquiry write us @  https://www.wiseguyreports.com/enquiry/1748998-global-parkinson-s-disease-drugs-market-outlook-2022

Table of Contents

1 Market Overview 
1. Analyst View 
2. Research Methodology 
3. Parkinson’s Disease: An Overview 
4. Market Dynamics 
4.1 Drivers 
4.1.1 Increasing Funding Support & Research Grants 
4.1.2 Increasing Awareness 
4.1.3 Rising Healthcare Expenditure 
4.1.4 Increasing Life Expectancy 
4.2 Challenges 
4.2.1 Patent Expiry of Blockbuster Drugs 
4.2.2 High Cost of Treatment 
4.2.3 Side Effects of Parkinson’s Disease Drugs 
4.3 Opportunities 
4.3.1 Collaboratios with Academic Institutions for Developing Innovative Solutions 
4.3.2 Reduction in “Off” Time to Improve Patient and Economic Outcomes 
4.3.3 Growing Geriatric Population 
5. Global Parkinson’s Disease Drugs Market Outlook 2022 
6. Major Products in Parkinson’s Disease Market 
6.1 Duodopa/Duopa 
6.2 Azilect 
6.3 Mirapex/Mirapex ER 
6.4 Requip 
6.5 Neupro 
6.6 Rytary/Numient 
6.7 Xadago 
6.8 Nuplazid 
7. Market Segmentation by Type of Therapy 
7.1 Levodopa Therapy 
7.2 Dopamine Agonist Therapy 
7.3 MAO-B Inhibitor Therapy 
7.4 COMT Inhibitor Therapy 
7.5 Other Therapy 
8. Market Segmentation by Geography 
8.1 North America 
8.2 Europe 
8.3 Asia-Pacific 
9. Trends & Developments 
9.1 Stem Cell Therapies - Revolutionizing Parkinson Treatment 
9.2 Incessant Launch of Novel Products 
10. Mergers & Acquisitions 
11. Drugs Pipeline of Parkinson’s Disease 
12. Company Profiles 
12.1 Abbvie Inc. 
12.2 Newron Pharmaceuticals SpA 
12.3 Acadia Pharmaceuticals Inc. 
12.4 Boehringer Ingelheim International GmbH 
12.5 Teva Pharmaceutical Industries Limited 
12.6 GlaxoSmithKline plc 
12.7 UCB S.A. 
12.8 Novartis AG 
12.9 Impax Laboratories, Inc. 
12.10 Valeant Pharmaceuticals International, Inc. 
12.11 Merck & Co., Inc. 
12.12 Mylan N.V. 
12.13 F. Hoffmann-La Roche Ltd. 
12.14 US WorldMeds, LLC

 Continued…………                                                                       

Buy now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1751707

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of research reports from hundreds of publishers worldwide. We boast a database spanning virtually every category and an even more comprehensive collection of research reports under these categories and sub-categories

Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
Pune - 411028 Maharashtra, India

This release was published on openPR.